FDA Sets Compliance Framework for Compounding Near Replicas of Approved Drugs

The FDA is laying out compliance parameters for outsourcing facilities that compound near replicas of approved drugs, urging them not to distribute such products to patients that could use an approved drug.
Source: Drug Industry Daily